Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography
Authors:
- 6 June 2000
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 742 (2) , 391-400
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: An open Belgian multicenter studyAtherosclerosis, 1994
- Knowledge-based system for the automated solid-phase extraction of basic drugs from plasma coupled with their liquid chromatographic determinationJournal of Chromatography A, 1994
- A comparison of the bioavailability of standard or micronized formulations of fenofibrateCurrent Therapeutic Research, 1993
- Automatic determination of diltiazem and desacetyldiltiazem in human plasma using liquid— solid extraction on disposable cartridges coupled to HPLC — Part II: Optimization of liquid—solid extractionJournal of Pharmaceutical and Biomedical Analysis, 1991
- Method validation in the bioanalytical laboratoryJournal of Pharmaceutical and Biomedical Analysis, 1990
- Clinical Significance of Esterases in ManClinical Pharmacokinetics, 1985
- Fenofibrate therapy of hyperlipoproteinaemia a dose—response study and a comparison with clofibrateAtherosclerosis, 1981
- Gas—liquid chromatographic determination of procetofenic acid in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1978
- Identification of a major metabolite of the new hypolipidaemic agent, isopropyl 2-[4′(p-chlorobenzoyl)phenoxy]-2-methylpropionate (procetofene) in humans by gas chromatography-mass spectrometryJournal of Chromatography A, 1976
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962